MVT-5873

N/A

Report date: 2022/08/29 20:00:24

Base Information

Drug NameMVT-5873
Drug Alias Name5B1HuMab 5BHuMab-5B1MVT-5873BNT-321
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionCA19.9(Carbohydrate antigen 19-9) modulators
TargetsCA19.9(Carbohydrate antigen 19-9)
Therapy Area/IndicationsPancreatic NeoplasmsLiver NeoplasmsColonic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMabvax Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer Institute
Inactive CompaniesBiontech SeBiontech Research & Development Inc
Active IndicationsPancreatic NeoplasmsLiver NeoplasmsColonic Neoplasms +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A